Developments in the scientific and clinical understanding of the spondyloarthritides, Arthritis Res. Ther, vol.11, p.208, 2009. ,
Inflammation in ankylosing spondylitis: a systematic description of the extent and frequency of acute spinal changes using magnetic resonance imaging, Ann. Rheum. Dis, vol.64, pp.730-734, 2005. ,
The natural course of radiographic progression in ankylosing spondylitis-evidence for major individual variations in a large proportion of patients, J. Rheumatol, vol.36, pp.997-1002, 2009. ,
The burden of ankylosing spondylitis, J. Rheumatol. Suppl, vol.78, pp.4-11, 2006. ,
Magnetic resonance imaging in spondyloarthritis, Curr. Opin. Rheumatol, vol.22, pp.381-388, 2010. ,
Magnetic resonance imaging in spondyloarthritis-how to quantify findings and measure response, Best Pract. Res. Clin. Rheumatol, vol.24, pp.637-57, 2010. ,
Which spinal lesions are associated with new bone formation in patients with ankylosing spondylitis treated with anti-TNF agents? A long-term observational study using MRI and conventional radiography, Ann. Rheum. Dis, vol.73, pp.1819-1844, 2014. ,
MRI inflammation at the vertebral unit only marginally predicts new syndesmophyte formation: a multilevel analysis in patients with ankylosing spondylitis, Ann. Rheum. Dis, vol.71, pp.369-73, 2012. ,
The role of positron emission tomography within the spectrum of medical imaging, Eur. J. Nucl. Med, vol.23, pp.207-218, 1996. ,
18F-FDG PET as a tool to predict the clinical outcome of infliximab treatment of rheumatoid arthritis: an explorative study, J. Nucl. Med. Off. Publ. Soc. Nucl. Med, vol.52, pp.77-80, 2011. ,
Assessment of disease activity in rheumatoid arthritis with (18)F-FDG PET, J. Nucl. Med. Off. Publ. Soc. Nucl. Med, vol.45, pp.956-64, 2004. ,
Dijkmans B a. C, Voskuyl AE. 2-Deoxy-2-[F-18]fluoro-D-glucose joint uptake on positron emission tomography images: rheumatoid arthritis versus osteoarthritis, Mol. Imaging Biol. MIB Off. Publ. Acad. Mol. Imaging, vol.9, pp.357-60, 2007. ,
Peripheral benzodiazepine receptor modulation with phagocyte differentiation, Biochem. Pharmacol, vol.46, pp.551-555, 1993. ,
Therapeutic impact of [(18)F]fluoride positron-emission tomography/computed tomography on patients with unclear foot pain, Skeletal Radiol, vol.39, pp.987-97, 2010. ,
The role of positron emission tomography in the management of bone metastases, Cancer, vol.88, pp.2927-2960, 2000. ,
Bone formation rather than inflammation reflects ankylosing spondylitis activity on PET-CT: a pilot study, Arthritis Res. Ther, vol.14, p.71, 2012. ,
High bone turnover assessed by 18F-fluoride PET/CT in the spine and sacroiliac joints of patients with ankylosing spondylitis: comparison with inflammatory lesions detected by whole body MRI, EJNMMI Res, vol.2, p.38, 2012. ,
Hybrid 18F-labeled Fluoride Positron Emission Tomography/Magnetic Resonance (MR) Imaging of the Sacroiliac Joints and the Spine in Patients with Axial Spondyloarthritis: A Pilot Study Exploring the Link of MR Bone Pathologies and Increased Osteoblastic Activity, J. Rheumatol, vol.42, pp.1631-1638, 2015. ,
Baseline increased 18Ffluoride uptake lesions at vertebral corners on positron emission tomography predict new syndesmophyte development in ankylosing spondylitis: a 2-year longitudinal study, Rheumatol. Int, vol.37, pp.765-73, 2017. ,
Inflammatory lesions of the spine on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis: evidence of a relationship between inflammation and new bone formation, Arthritis Rheum, vol.60, pp.93-102, 2009. ,
Imaging of Ankylosing Spondylitis By [18f]Fluoride PET-CT to Assess Bone Formation Activity and to Monitor Anti-TNF Therapy ,
, Arthritis Rheumatol, 201668.
, Lancet Lond. Engl, vol.377, pp.2127-2164, 2011.
Ankylosing spondylitis, spondyloarthropathy, spondyloarthritis, or spondylarthritis: what's in a name? Jt, Bone Spine Rev. Rhum, vol.79, pp.534-539, 2012. ,
Concepts and epidemiology of spondyloarthritis, Best Pract. Res. Clin. Rheumatol, vol.20, pp.401-418, 2006. ,
Prevalence of spondyloarthropathies in France, Ann. Rheum. Dis, vol.64, pp.1431-1436, 2001. ,
Developments in the scientific and clinical understanding of the spondyloarthritides, Arthritis Res. Ther, vol.11, p.208, 2009. ,
The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection, Ann. Rheum. Dis, vol.68, pp.777-83, 2009. ,
Ankylosing spondylitis. The Lancet, vol.369, pp.1379-90, 2007. ,
URL : https://hal.archives-ouvertes.fr/hal-00503871
Role of HLA-B27 in the pathogenesis of ankylosing spondylitis (Review), Mol. Med. Rep, vol.15, pp.1943-51, 2017. ,
Developments in the scientific and clinical understanding of the spondyloarthritides, Arthritis Res. Ther, vol.11, p.208, 2009. ,
Prevalence of ankylosing spondylitis in males and females in a young middle-aged population of Tromsø, northern Norway, Ann. Rheum. Dis, vol.44, pp.359-67, 1985. ,
Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors, Arthritis Rheum, vol.41, pp.58-67, 1998. ,
The epidemiology of ankylosing spondylitis, Semin. Arthritis Rheum, vol.22, pp.319-353, 1993. ,
The challenge of diagnosis and classification in early ankylosing spondylitis: do we need new criteria?, Arthritis Rheum, vol.52, pp.1000-1008, 2005. ,
Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria, Arthritis Rheum, vol.27, pp.361-369, 1984. ,
Spondylitic disease without radiologic evidence of sacroiliitis in relatives of HLA-B27 positive ankylosing spondylitis patients, Arthritis Rheum, vol.28, pp.40-43, 1985. ,
Diagnostic features of ankylosing spondylitis, Br. J. Rheumatol, vol.34, pp.301-304, 1995. ,
Clinical features and prognosis of patients with possible ankylosing spondylitis. Results of a 10-year followup, J. Rheumatol, vol.15, pp.1109-1123, 1988. ,
The familial form of spondylarthropathy: a clinical study of 115 multiplex families. Groupe Français d'Etude Génétique des Spondylarthropathies, Arthritis Rheum, vol.43, pp.1356-65, 2000. ,
, Rev. Rhum. Mal. Osteoartic, vol.57, pp.85-94, 1990.
The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy, Arthritis Rheum, vol.34, pp.1218-1245, 1991. ,
Evaluation of diagnostic criteria for ankylosing spondylitis: a comparison of the Rome, New York and modified New York criteria in patients with a positive clinical history screening test for ankylosing spondylitis, Br. J. Rheumatol, vol.24, pp.242-251, 1985. ,
The Nonradiographic Axial Spondyloarthritis, the Radiographic Axial Spondyloarthritis, and Ankylosing Spondylitis: The Tangled Skein of Rheumatology, Int. J. Rheumatol, 2017. ,
Early detection of sacroiliitis on magnetic resonance imaging and subsequent development of sacroiliitis on plain radiography. A prospective, longitudinal study, J. Rheumatol, vol.26, pp.1953-1961, 1999. ,
The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal, Ann. Rheum. Dis, vol.68, pp.770-776, 2009. ,
The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general, Ann. Rheum. Dis, vol.70, pp.25-31, 2011. ,
Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci, International Genetics of Ankylosing Spondylitis Consortium (IGAS), vol.45, pp.730-738, 2013. ,
HLA-B27: what's new? Rheumatol, Oxf. Engl, vol.49, pp.621-652, 2010. ,
What is the role of HLA-B27 in spondyloarthropathies?, Autoimmun. Rev, vol.10, pp.464-472, 2011. ,
Progress in the genetics of ankylosing spondylitis, Brief. Funct. Genomics, vol.10, pp.249-57, 2011. ,
Expression of cathepsin K and matrix metalloproteinase 1 indicate persistent osteodestructive activity in longstanding ankylosing spondylitis, Ann. Rheum. Dis, vol.68, pp.1334-1343, 2009. ,
Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis, Arthritis Rheum, vol.38, pp.499-505, 1995. ,
Inflammation and destruction of the joints-the Wnt pathway, Jt. Bone Spine Rev. Rhum, vol.75, pp.105-112, 2008. ,
Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitis, Arthritis Rheum, vol.60, pp.3257-62, 2009. ,
Investigation of involved tissue in axial spondyloarthritis-what have we learnt from immunohistochemical studies?, Best Pract. Res. Clin. Rheumatol, vol.24, pp.715-724, 2010. ,
Progress in spondylarthritis. Mechanisms of new bone formation in spondyloarthritis, Arthritis Res. Ther, vol.11, p.221, 2009. ,
Prostaglandin E2 stimulates bone sialoprotein (BSP) expression through cAMP and fibroblast growth factor 2 response elements in the proximal promoter of the rat BSP gene, J. Biol. Chem, vol.278, pp.28659-67, 2003. ,
Selection of instruments in the core set for DC-ART, SMARD, physical therapy, and clinical record keeping in ankylosing spondylitis. Progress report of the ASAS Working Group. Assessments in Ankylosing Spondylitis, J. Rheumatol, vol.26, pp.951-955, 1999. ,
,
, ASAS/EULAR recommendations for the management of ankylosing spondylitis, Ann. Rheum. Dis, vol.65, pp.442-52, 2006.
2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis, Ann. Rheum. Dis, vol.70, pp.896-904, 2011. ,
Physical function in ankylosing spondylitis is independently determined by both disease activity and radiographic damage of the spine, Ann. Rheum. Dis, vol.68, pp.863-870, 2009. ,
What is the most appropriate radiologic scoring method for ankylosing spondylitis? A comparison of the available methods based on the Outcome Measures in Rheumatology Clinical Trials filter, Arthritis Rheum, vol.50, pp.2622-2654, 2004. ,
Selection of a method for scoring radiographs for ankylosing spondylitis clinical trials, by the Assessment in Ankylosing Spondylitis Working Group and OMERACT, J. Rheumatol, vol.32, pp.2048-2057, 2005. ,
Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system, Ann. Rheum. Dis, vol.64, pp.127-136, 2005. ,
Development of a radiographic scoring tool for ankylosing spondylitis only based on bone formation: addition of the thoracic spine improves sensitivity to change, Arthritis Rheum, vol.61, pp.764-71, 2009. ,
The OMERACT filter for Outcome Measures in Rheumatology, J. Rheumatol, vol.25, pp.198-207, 1998. ,
Scoring radiographic progression in ankylosing spondylitis: should we use the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) or the Radiographic Ankylosing Spondylitis Spinal Score (RASSS)?, Arthritis Res. Ther, vol.15, p.14, 2013. ,
DOI : 10.1186/ar4144
URL : https://arthritis-research.biomedcentral.com/track/pdf/10.1186/ar4144
New tools for diagnosing spondyloarthropathy, Jt. Bone Spine Rev. Rhum, vol.77, pp.108-122, 2010. ,
DOI : 10.1016/j.jbspin.2009.12.005
Imaging for the diagnosis and follow-up of ankylosing spondylitis: development of recommendations for clinical practice based on published evidence and expert opinion, Jt. Bone Spine Rev. Rhum, vol.74, pp.338-383, 2007. ,
URL : https://hal.archives-ouvertes.fr/hal-00465284
Magnetic resonance imaging of inflammatory lesions in the spine in ankylosing spondylitis clinical trials: is paramagnetic contrast medium necessary?, J. Rheumatol, vol.32, pp.2056-60, 2005. ,
Spinal changes in patients with spondyloarthritis: comparison of MR imaging and radiographic appearances, Radiogr. Rev. Publ. Radiol. Soc. N. Am. Inc, vol.25, pp.559-569, 2005. ,
Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group, Ann. Rheum. Dis, vol.68, pp.1520-1527, 2009. ,
The diagnostic utility of MRI in spondyloarthritis, Best Pract. Res. Clin. Rheumatol, vol.26, pp.751-66, 2012. ,
Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group, Ann. Rheum. Dis, vol.68, pp.1520-1527, 2009. ,
Descriptions of spinal MRI lesions and definition of a positive MRI of the spine in axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI study group, Ann. Rheum. Dis, vol.71, pp.1278-88, 2012. ,
Magnetic resonance imaging in spondyloarthritis, Curr. Opin. Rheumatol, vol.22, pp.381-388, 2010. ,
Evaluation of the diagnostic utility of spinal magnetic resonance imaging in axial spondylarthritis, Arthritis Rheum, vol.60, pp.1331-1372, 2009. ,
The fatty Romanus lesion: a non-inflammatory spinal MRI lesion specific for axial spondyloarthropathy, Ann. Rheum. Dis, vol.69, pp.891-895, 2010. ,
DOI : 10.1136/ard.2009.112094
, Growth and Remodeling. In: De Groot LJ, 2000.
A single measurement of biochemical markers of bone turnover has limited utility in the individual person, Scand. J. Clin. Lab. Invest, vol.57, pp.351-360, 1997. ,
Fluorine-18: a new isotope for bone scanning, J. Nucl. Med. Off. Publ. Soc. Nucl. Med, vol.3, pp.332-336, 1962. ,
Clinical utility of (18)F-fluoride PET/CT in benign and malignant bone diseases, Bone, vol.50, pp.128-167, 2012. ,
The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, singleand multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT, J. Nucl. Med. Off. Publ. Soc. Nucl. Med, vol.47, pp.287-97, 2006. ,
Bone formation rather than inflammation reflects ankylosing spondylitis activity on PET-CT: a pilot study, Arthritis Res. Ther, vol.14, p.71, 2012. ,
DOI : 10.1186/ar3792
URL : https://arthritis-research.biomedcentral.com/track/pdf/10.1186/ar3792
18F-fluoride PET/CT for detection of axial involvement in ankylosing spondylitis: correlation with disease activity, Ann. Nucl. Med, vol.30, pp.430-434, 2016. ,
Hybrid 18Flabeled Fluoride Positron Emission Tomography/Magnetic Resonance (MR) Imaging of the Sacroiliac Joints and the Spine in Patients with Axial Spondyloarthritis: A Pilot Study Exploring the Link of MR Bone Pathologies and Increased Osteoblastic Activity, J. Rheumatol, vol.42, pp.1631-1638, 2015. ,
High bone turnover assessed by 18F-fluoride PET/CT in the spine and sacroiliac joints of patients with ankylosing spondylitis: comparison with inflammatory lesions detected by whole body MRI, EJNMMI Res, vol.2, p.38, 2012. ,
Assessment of bone synthetic activity in inflammatory lesions and syndesmophytes in patients with ankylosing spondylitis: the potential role of 18F-fluoride positron emission tomography-magnetic resonance imaging, Clin. Exp. Rheumatol, vol.33, pp.90-97, 2015. ,
Baseline increased 18F-fluoride uptake lesions at vertebral corners on positron emission tomography predict new syndesmophyte development in ankylosing spondylitis: a 2-year longitudinal study, Rheumatol. Int, vol.37, pp.765-73, 2017. ,
18Ffluoride PET/CT for detection of sacroiliitis in ankylosing spondylitis, Eur. J. Nucl. Med. Mol. Imaging, vol.37, pp.1760-1765, 2010. ,
Which spinal lesions are associated with new bone formation in patients with ankylosing spondylitis treated with anti-TNF agents? A long-term observational study using MRI and conventional radiography, Ann. Rheum. Dis, vol.73, pp.1819-1844, 2014. ,
MRI inflammation at the vertebral unit only marginally predicts new syndesmophyte formation: a multilevel analysis in patients with ankylosing spondylitis, Arthritis Res. Ther, vol.10, pp.369-73, 2008. ,
Inflammatory lesions of the spine on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis: evidence of a relationship between inflammation and new bone formation, Arthritis Rheum, vol.60, pp.93-102, 2009. ,
Syndesmophyte growth in ankylosing spondylitis, Curr. Opin. Rheumatol, vol.27, pp.326-358, 2015. ,
,
, Fluoride PET-CT to Assess Bone Formation Activity and to Monitor Anti-TNF Therapy
, Arthritis Rheumatol, issue.10, 201668.